Tango Therapeutics
Develops precision cancer medicines using synthetic lethality principles.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2017
- Employees
- 155
- Headquarters
- United States
- Type
- Public
- Listed
- Nasdaq Capital Market: TNGX
- Subsidiaries
- Tango Therapeutics Sub, Inc., Tango Securities Corporation
6 jobs